Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma.
about
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewSoft tissue reconstruction of the foot using the distally based island pedicle flap after resection of malignant melanoma.A critical assessment of treatment options for idiopathic pulmonary fibrosis.Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process.Current management of melanoma: benefits of surgical staging and adjuvant therapy.Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).Childhood melanoma: update and treatment.Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.Melanoma survival in the United States, 1992 to 2005.Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma.What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.Desmoplastic and neurotropic melanoma.Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?
P2860
Q28394719-90154699-54B8-406C-AE04-AF7366EC0963Q34312103-DDF980F3-7FD4-41EE-B364-4701B4F2ACBDQ34562973-C29C2E52-73CA-466E-AE0C-D5DCA893DAF4Q34894172-DDF39085-3C2C-4F0D-9340-C4FF804DF7CBQ35069314-6C7BA552-8BE9-423A-B69A-C26C26271D54Q35078687-E0BD5EB2-6363-439D-A0E8-C0C656BFC187Q35895132-7901D807-7A24-44E2-B773-865F1D62B1FDQ36245848-5493900D-D02F-44A6-9D9A-E9BC67984F4DQ36626905-7BE522B5-6EDC-45B8-B369-C78B3BC113E0Q36961188-BB26FD66-688B-46C7-B418-B3B0BAEDA307Q39945198-0C802850-69F9-471C-9EBA-15F97C53195BQ44935187-EB661D7E-5931-4CBC-9E26-7730C41E027BQ47239407-ACF06304-05A8-4606-9611-158370C86F30Q54791477-3CF21FB1-4EB0-4D73-AB2A-F8823DA4BD69
P2860
Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Developing indications for the ...... nterferon alfa-2b in melanoma.
@ast
Developing indications for the ...... nterferon alfa-2b in melanoma.
@en
Developing indications for the ...... nterferon alfa-2b in melanoma.
@nl
type
label
Developing indications for the ...... nterferon alfa-2b in melanoma.
@ast
Developing indications for the ...... nterferon alfa-2b in melanoma.
@en
Developing indications for the ...... nterferon alfa-2b in melanoma.
@nl
prefLabel
Developing indications for the ...... nterferon alfa-2b in melanoma.
@ast
Developing indications for the ...... nterferon alfa-2b in melanoma.
@en
Developing indications for the ...... nterferon alfa-2b in melanoma.
@nl
P2093
P1433
P1476
Developing indications for the ...... nterferon alfa-2b in melanoma.
@en
P2093
J Kirkwood
K McMasters
R W Dubois
S J Miller
S M Swetter
P304
P356
10.1001/ARCHDERM.137.9.1217
P577
2001-09-01T00:00:00Z